**Core Concept**
A Partial Thromboplastin Time (PTT) is a coagulation test used to evaluate the intrinsic and common pathways of the coagulation cascade. It measures the time it takes for blood to clot after adding a substance that activates the coagulation cascade, such as tissue factor.

**Why the Correct Answer is Right**
The PTT is required for monitoring of heparin therapy. Heparin works by inhibiting thrombin formation, which is a key step in the coagulation cascade. By inhibiting thrombin, heparin prolongs the PTT. Regular monitoring of PTT is necessary to ensure that the heparin dose is adequate to prevent thrombosis but not so high as to cause bleeding.

**Why Each Wrong Option is Incorrect**
**Option A:** Warfarin therapy is monitored using the Prothrombin Time (PT), not PTT. Warfarin inhibits vitamin K-dependent clotting factors, which affects the extrinsic pathway.
**Option B:** Direct oral anticoagulants (DOACs) like rivaroxaban do not require PTT monitoring. Instead, their anticoagulant activity is monitored using specific assays for each drug.
**Option C:** Platelet disorders, such as thrombocytopenia or platelet dysfunction, may affect bleeding time, but PTT is not the relevant test for monitoring platelet function.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that PTT is a sensitive test for heparin-induced thrombocytopenia, a potentially life-threatening complication of heparin therapy.

**Correct Answer:** D. Heparin therapy.